Monoclonal antibody · Inhibitor of 5'-ecto-nucleotidase (CD73) (NT5E)
Phase 1/2Most advanced trial
1Registered trials
What is S095024?
S095024 is a monoclonal antibody that binds CD73 (NT5E), an ectoenzyme that converts extracellular AMP to adenosine, and inhibits its activity. By reducing adenosine-mediated immunosuppression, it is intended to enhance cytotoxic T-lymphocyte activity. It is studied in non-small cell lung cancer.
Summary written with AI from the sources listed at the end of this page.
At a glance
Drug type
Monoclonal antibody
Targets
5'-ecto-nucleotidase (CD73) (NT5E)
Mechanism
Inhibitor of 5'-ecto-nucleotidase (CD73) (NT5E)
Pathways
adenosine-mediated immunosuppression, CD73-mediated conversion of AMP to adenosine
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.